States reach deal over marketing, safety of generic opioids
A former opioid manufacturer is agreeing in principle to pay up to $2.4 billion in a deal with a dozen states over its marketing and product safety practices.
State attorneys general announced the deal Friday regarding Allergan’s practices.
Allergan is now part of AbbVie but sold its generics division Actavis, including its opioid products, to Teva Pharmaceuticals six years ago.
The settlement calls for payments to be made to state and local governments.
The agreement means pharma companies have consented to pay more than $40 billion to settle opioid crisis claims regarding manufacturers and distributors, The Associated Press has found.
This is a developing story. Check back for updates as more information becomes available.
Download the FREE WPXI News app for breaking news alerts.
Follow Channel 11 News on Facebook and Twitter. | Watch WPXI NOW
TRENDING NOW:
Pittsburgh police warning residents of crimes involving teens using USB cords to steal cars 2 people killed, 3 injured after 2 vehicle crash in Fayette County Arrest warrant out for man accused of attacking Crafton Giant Eagle employee VIDEO: Former Greensburg-based dentist testifies in court, tells jury he did not kill his wife DOWNLOAD the Channel 11 News app for breaking news alerts
